Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Authors' response.
Hiramatsu K, Ueda Y, Yoshino K, Fujita M, Morii E, Enomoto T, Kimura T. Hiramatsu K, et al. Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):297. doi: 10.1016/j.ejogrb.2013.07.001. Epub 2013 Aug 1. Eur J Obstet Gynecol Reprod Biol. 2013. PMID: 23910169 No abstract available.
Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer.
Matsuo K, Yoshino K, Hiramatsu K, Banzai C, Hasegawa K, Yasuda M, Nishimura M, Sheridan TB, Ikeda Y, Shiki Y, Mabuchi S, Enomoto T, Kimura T, Fujiwara K, Roman LD, Sood AK. Matsuo K, et al. Among authors: hiramatsu k. Obstet Gynecol. 2014 May;123(5):957-965. doi: 10.1097/AOG.0000000000000240. Obstet Gynecol. 2014. PMID: 24785846 Free PMC article.
Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.
Matsuo K, Hasegawa K, Yoshino K, Murakami R, Hisamatsu T, Stone RL, Previs RA, Hansen JM, Ikeda Y, Miyara A, Hiramatsu K, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Roman LD, Gabra H, Fotopoulou C, Sood AK. Matsuo K, et al. Among authors: hiramatsu k. Eur J Cancer. 2015 Sep;51(14):1978-88. doi: 10.1016/j.ejca.2015.07.012. Epub 2015 Jul 31. Eur J Cancer. 2015. PMID: 26238017 Free PMC article.
Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.
Matsuzaki S, Serada S, Hiramatsu K, Nojima S, Matsuzaki S, Ueda Y, Ohkawara T, Mabuchi S, Fujimoto M, Morii E, Yoshino K, Kimura T, Naka T. Matsuzaki S, et al. Among authors: hiramatsu k. Int J Cancer. 2018 Mar 1;142(5):1056-1066. doi: 10.1002/ijc.31124. Epub 2017 Oct 31. Int J Cancer. 2018. PMID: 29055044 Free article.
1,407 results